Karyopharm Therapeutics Inc. (KPTIQ)
OTCMKTS · Delayed Price · Currency is USD
0.0254
-0.0001 (-0.39%)
At close: Nov 13, 2026
Karyopharm Therapeutics Market Cap
Karyopharm Therapeutics has a market cap or net worth of $576.11 thousand as of November 13, 2026. Its market cap has decreased by 99.40% in one year.
Market Cap
576.11K
Enterprise Value
264.00M
Revenue
146.62M
Global Rank
n/a
Country Rank
n/a
PE Ratio
n/a
ChartMarket Cap Chart
Since November 7, 2013, Karyopharm Therapeutics's market cap has decreased from 459.10M to 576.11K, a decrease of -99.87%. That is a compound annual growth rate of -40.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 576.11K | -99.57% |
| Dec 31, 2025 | 134.76M | 57.91% |
| Dec 31, 2024 | 85.34M | -13.86% |
| Dec 29, 2023 | 99.07M | -74.26% |
| Dec 30, 2022 | 384.92M | -20.76% |
| Dec 31, 2021 | 485.77M | -57.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SQZ Biotechnologies Company | 707.79K |
| Neon Bloom | 509.43K |
| Regenerative Medical Technology Group | 448.77K |
| Mosaic ImmunoEngineering | 434.53K |
| Altamira Therapeutics | 404.66K |
| Aditxt | 399.19K |
| Actavia Life Sciences | 385.91K |
| CERo Therapeutics Holdings | 379.61K |